Pharmaceutical GDP compliance and standardization

In the new virus age, the need for rigorous compliance with regulations and strict adherence to best-practice surrounding the quality, safe, and efficient distribution of medicines and vaccines worldwide has never been greater.

We are bringing together a collaborative partnership with Poseidon, the independent pharmaceutical logistics collaboration network, with the objective of bringing greater quality, and certainty to the global distribution of medicines and vaccines. With our joint resources and expertise we are to develop and execute a multi-mode compliance and standards (MMCS) program to help promote, standardize, monitor and assess adherence to the GDP (good distribution practice) regulations that underpin global pharmaceutical logistics. The development of standards and the furtherance of assessment and training will form part of the program scope.

The MMCS program is relevant to pharmaceutical shippers, their end-to-end distribution partners and the wider community. The program will interpret the prevailing local and international GDP regulations and guidelines for each of the main long-haul transport modes and provide a full range of GDP support components, from collaborative standard development, to a shared assessment model, to training services.

The MMCS GDP initiative, the first of its type, promises to play a pivotal role in the pharmaceutical industry's drive for greater collaboration around supply chain standardization, resilience and regulatory conformance.

Find out more from the below webinar: